These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
165 related articles for article (PubMed ID: 30303133)
1. Expression of α-smooth muscle actin in benign and malignant salivary gland tumors: An immunohistochemical study. Ravi M; Boaz K; Natarajan S; Lewis A; Prasad M; Yellapurkar S Indian J Pathol Microbiol; 2018; 61(4):479-484. PubMed ID: 30303133 [TBL] [Abstract][Full Text] [Related]
2. Selective immunohistochemical comparison of polymorphous low-grade adenocarcinoma and adenoid cystic carcinoma. Beltran D; Faquin WC; Gallagher G; August M J Oral Maxillofac Surg; 2006 Mar; 64(3):415-23. PubMed ID: 16487803 [TBL] [Abstract][Full Text] [Related]
3. Salivary gland tumors: immunohistochemical study of EGF, EGFR, ErbB-2, FAS and Ki-67. Ito FA; Ito K; Coletta RD; Graner E; de Almeida OP; Lopes MA Anal Quant Cytol Histol; 2009 Oct; 31(5):280-7. PubMed ID: 20701095 [TBL] [Abstract][Full Text] [Related]
4. Comparison of p63/p40 Expression With Myoepithelial Markers in Minor Salivary Gland Tumors. Teixeira LN; Janner ÉC; Teixeira T; Passador-Santos F; Martinez EF; Demasi APD; de Araújo NS; de Araújo VC Int J Surg Pathol; 2019 Jun; 27(4):360-371. PubMed ID: 30482064 [TBL] [Abstract][Full Text] [Related]
5. Low-grade mucoepidermoid carcinoma of salivary glands: characteristic immunohistochemical profile and evidence of striated duct differentiation. Foschini MP; Marucci G; Eusebi V Virchows Arch; 2002 May; 440(5):536-42. PubMed ID: 12021929 [TBL] [Abstract][Full Text] [Related]
6. Thomsen-Friedenreich (T) antigen as marker of myoepithelial and basal cells in the parotid gland, pleomorphic adenomas and adenoid cystic carcinomas. An immunohistological comparison between T and sialosyl-T antigens, alpha-smooth muscle actin and cytokeratin 14. Therkildsen MH; Mandel U; Christensen M; Dabelsteen E APMIS; 1995; 103(7-8):558-67. PubMed ID: 7576573 [TBL] [Abstract][Full Text] [Related]
7. Keratin 14 immunoreactive cells in pleomorphic adenomas and adenoid cystic carcinomas of salivary glands. Ogawa Y; Toyosawa S; Ishida T; Ijuhin N Virchows Arch; 2000 Jul; 437(1):58-68. PubMed ID: 10963381 [TBL] [Abstract][Full Text] [Related]
8. The myoepithelial immunophenotype in 135 benign and malignant salivary gland tumors other than pleomorphic adenoma. Prasad AR; Savera AT; Gown AM; Zarbo RJ Arch Pathol Lab Med; 1999 Sep; 123(9):801-6. PubMed ID: 10458827 [TBL] [Abstract][Full Text] [Related]
9. Assessment of p63 expression in the salivary gland neoplasms adenoid cystic carcinoma, polymorphous low-grade adenocarcinoma, and basal cell and canalicular adenomas. Edwards PC; Bhuiya T; Kelsch RD Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2004 May; 97(5):613-9. PubMed ID: 15153875 [TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical expression of CA19-9 and CA125 in mucoepidermoid and adenoid cystic carcinomas of the salivary gland. Okamura K; Kiyoshima T; Shima K; Kobayashi I; Matsuo K; Ishibashi H; Komatsu S; Rasul AM; Sakai H Oral Oncol; 2002 Apr; 38(3):244-50. PubMed ID: 11978546 [TBL] [Abstract][Full Text] [Related]
11. Comparison of Diagnostic Reliability of p63 and Smooth Muscle Actin in Salivary Gland Neoplasms. Aswani E; Sherlin HJ; Jayaraj G; Don KR; Santhanam A Indian J Otolaryngol Head Neck Surg; 2022 Oct; 74(Suppl 2):2520-2526. PubMed ID: 36452668 [TBL] [Abstract][Full Text] [Related]
13. Hyaluronan and CD44 expression in minor salivary gland tumors. Xing R; Regezi JA; Stern M; Shuster S; Stern R Oral Dis; 1998 Dec; 4(4):241-7. PubMed ID: 10200702 [TBL] [Abstract][Full Text] [Related]
14. Benign, malignant salivary gland tumors: comparison of immunohistochemical expression of e-cadherin. Prabhu S; Kaveri H; Rekha K Oral Oncol; 2009 Jul; 45(7):594-9. PubMed ID: 18955011 [TBL] [Abstract][Full Text] [Related]
15. SOX10-positive salivary gland tumors: a growing list, including mammary analogue secretory carcinoma of the salivary gland, sialoblastoma, low-grade salivary duct carcinoma, basal cell adenoma/adenocarcinoma, and a subgroup of mucoepidermoid carcinoma. Hsieh MS; Lee YH; Chang YL Hum Pathol; 2016 Oct; 56():134-42. PubMed ID: 27327192 [TBL] [Abstract][Full Text] [Related]
16. Immunohistochemical study of salivary gland tumors in a tertiary institution in South-South Region of Nigeria. Omitola OG; Iyogun CA J Oral Maxillofac Pathol; 2018; 22(2):163-167. PubMed ID: 30158766 [TBL] [Abstract][Full Text] [Related]
17. Actin versus vimentin in myoepithelial cells of salivary gland tumors. A comparative study. de Araujo VC; Carvalho YR; de Araujo NS Oral Surg Oral Med Oral Pathol; 1994 Apr; 77(4):387-91. PubMed ID: 8015803 [TBL] [Abstract][Full Text] [Related]
18. Epithelial membrane antigen and DOG1 expression in minor salivary gland tumours. Andrade EP; Teixeira LN; Montalli VAM; Garcia FM; Passador-Santos F; Soares AB; Araújo VC Ann Diagn Pathol; 2019 Dec; 43():151408. PubMed ID: 31629156 [TBL] [Abstract][Full Text] [Related]
19. Polymorphous low-grade adenocarcinoma and adenoid cystic carcinoma: a review and comparison of immunohistochemical markers. Darling MR; Schneider JW; Phillips VM Oral Oncol; 2002 Oct; 38(7):641-5. PubMed ID: 12167416 [TBL] [Abstract][Full Text] [Related]
20. Utility of smooth muscle actin and CD117 as reliable markers in the diagnosis of salivary gland neoplasms. Raman S; Sherlin HJ J Oral Maxillofac Pathol; 2019; 23(2):218-223. PubMed ID: 31516227 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]